TYLIFA

Trademark usage description

pharmaceuticals for the treatment of oncological disorders and diseases; pharmaceuticals and biological preparations made from human blood cells for m Read More

Classification Information

Class [005]
Pharmaceuticals for the treatment of oncological disorders and diseases; pharmaceuticals and biological preparations made from human blood cells for medical use and for the treatment of oncological disorders and diseases.

Classification kind code

Class [044]
Medical services, namely, modification of cells for the treatment of cancer, and other diseases and medical conditions; immunotherapy treatments; medical diagnosis and treatment services; providing information relating to oncology and immunotherapy treatment; providing medical information and medical consultancy services in the field of oncology; collection and preservation of biological tissue.

Classification kind code

Mark Details

Serial Number

1947691

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 2^th Aug 2023	Advertised
Submitted for opposition 27 on 7^th Jul 2023	Approval Notice Sent
Submitted for opposition 26 on 7^th Jul 2023	Approved
Submitted for opposition 67 on 7^th Oct 2022	Agent Name Changed
Submitted for opposition 22 on 29^th Sept 2022	Search Recorded
Submitted for opposition 20 on 29^th Sept 2022	Examiner's First Report
Submitted for opposition 67 on 11^th Sept 2019	Agent Name Changed
Submitted for opposition 31 on 26^th Feb 2019	Formalized
Submitted for opposition 1 on 25^th Feb 2019	Created
Submitted for opposition 30 on 22^nd Feb 2019	Filed

TYLIFA

Classification Information

Class [005]Pharmaceuticals for the treatment of oncological disorders and diseases; pharmaceuticals and biological preparations made from human blood cells for medical use and for the treatment of oncological disorders and diseases.

Classification kind code

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceuticals for the treatment of oncological disorders and diseases; pharmaceuticals and biological preparations made from human blood cells for medical use and for the treatment of oncological disorders and diseases.